Director - Global Quality Compliance
Description
Position Summary
The Director, Global Quality Compliance is
a senior enterprise leadership role accountable for shaping and advancing GMP compliance,
quality risk management, and continuous improvement across WuXi Biologics’ global network in China, the United States, Europe, and Asia.
The role establishes globally consistent,
risk-based compliance expectations while enabling effective execution at site
and functional levels. It provides strategic oversight across biologics drug
substance and drug product operations, sterile drug products, quality control
laboratories, combination products, and emerging modalities, supporting
products from clinical development through commercialization in multiple
markets.
The successful candidate will be a credible GMP
authority and influential enterprise leader who can translate evolving
regulatory expectations into practical governance, anticipate systemic compliance
risk, guide senior stakeholders, and lead complex cross-functional remediation
and transformation programs.
Key Accountabilities
1. Global GMP Compliance Strategy &
Governance
·
Shape
and execute the global GMP compliance and quality risk management strategy in
alignment with business priorities, product lifecycle needs, and regulatory
commitments.
· Establish and sustain
harmonized global policies, standards, governance structure and practice, and
performance mechanisms based on applicable regulations, guidance, and industry
best practices.
· Define enterprise compliance
risk criteria, maintain a global risk register, and ensure timely escalation,
mitigation, and leadership visibility of significant risks.
· Assess the effectiveness and
health of pharmaceutical quality systems at global and site levels, including
deviation management, CAPA, change control, data integrity, and management
review.
·
Drive
consistent interpretation of global requirements while enabling fit-for-purpose
site execution and clear accountability.
2. Regulatory Intelligence & Compliance
·
Maintain oversight of evolving requirements and
expectations from FDA, EMA, NMPA, PMDA, PIC/S, ICH, and other health
authorities and standards-setting bodies.
· Lead the
global process for regulatory intelligence, impact assessment, gap analysis,
prioritization, implementation, and effectiveness verification.
· Translate
new regulatory, compendial, and technical expectations into practical global
standards and implementation plans.
· Provide
authoritative compliance guidance for complex or high-risk issues and support
defensible, science- and risk-based decisions.
3. Inspection Readiness &
Regulatory Response
·
Set the global framework for sustained
inspection readiness across manufacturing sites, laboratories, and relevant
corporate functions.
· Provide
leadership and subject-matter support for significant regulatory inspections,
including preparation, inspection conduct, response strategy, and
post-inspection remediation.
· Ensure
observations and commitments are assessed for systemic impact, addressed
through robust CAPA, and verified for effectiveness across the network.
· Identify
inspection trends and recurring vulnerabilities, and sponsor enterprise-level corrective
and preventive improvement.
4. Global Audit &
Compliance Oversight
·
Design and lead a risk-based global audit and
oversight strategy covering internal sites, suppliers, contract laboratories,
computerized systems, and other GxP service providers.
· Provide
governance for regulatory inspections, critical client and partner audits and
support coordinated preparation, response, and follow-up.
· Set
expectations for auditor qualification, audit planning, report quality, finding
classification, CAPA robustness, and effectiveness verification.
· Analyze
audit data and trends to identify systemic risk and prioritize network-wide
remediation and continuous improvement.
5. Digital, Computerized
Systems & AI Compliance
·
Advise on GxP compliance of data integrity,
validation, and lifecycle controls for computerized systems, digital
transformation, automation, and AI-enabled solutions.
· Help
establish risk-based governance for the selection, development, validation,
deployment, monitoring, change, and retirement of GxP digital and AI solutions.
· Partner with
Quality, IT, Digital, Data, Legal, and business functions to ensure innovation
is implemented with appropriate controls, accountability, and regulatory
defensibility.
6. New Businesses, Modalities
& Product Lifecycle
·
Provide compliance leadership for new or
expanding businesses, facilities, technologies, and modalities, ensuring
fit-for-purpose quality systems are established early and scaled appropriately.
· Advise on
quality and regulatory considerations for combination products, including
drug–device interfaces, and for antibody conjugates and other innovative therapeutic
protein platforms.
· Support due
diligence, technology transfer, launch readiness, and lifecycle changes where
significant GMP compliance risk is present.
7. Enterprise Leadership
& Quality Culture
·
Build, lead, and develop a high-performing
global compliance team and broader network of quality professionals, as
applicable.
· Influence
senior leaders across functions and regions and promote a strong quality
culture, transparent escalation, and risk-based decision-making.
· Chair or
contribute to senior governance forums and communicate compliance health,
emerging risk, and remediation status clearly and concisely.
· Serve as a
trusted advisor to executive and site leadership on strategic initiatives,
significant quality events, and complex regulatory matters.
·
Define meaningful metrics and management
insights that drive accountability, early intervention, and sustainable
improvement.
Required Qualifications
o
Bachelor’s degree in life science, health
sciences, regulatory science, biomedicine or a related discipline; an advanced
degree is preferred.
o Typically
12+ years of progressive quality compliance, or regulatory experience in a
regulatory agency, biologics, biopharmaceuticals, or CDMO/CMO environments,
including substantial leadership responsibility.
o Demonstrated
success leading global or multi-site GMP compliance programs and influencing
outcomes at senior leadership level.
o Deep working
knowledge of pharmaceutical quality systems and GMP compliance across biologics
drug substance and drug product operations, sterile manufacturing, and quality
control laboratories.
o Strong
command of major global GMP frameworks and regulatory expectations, with the
ability to interpret requirements and apply sound scientific and risk-based
judgment.
o Proven leadership
in regulatory inspections, complex audits, significant compliance
investigations, and enterprise-scale remediation or transformation programs.
o Ability to
identify systemic risk, set priorities under ambiguity, and balance compliance,
patient protection, operational realities, and business continuity.
o Exceptional
executive communication, stakeholder influence, negotiation, and
decision-making skills in a global matrix organization.
o Fluency in
English and Chinese, with the ability to communicate complex quality and
regulatory matters clearly across cultures and functions.
Preferred Experience
·
Experience gained in a leading multinational
biopharmaceutical company, global CDMO, or health authority.
· Leadership
of major pre-approval, routine GMP, or for-cause inspections and successful
post-inspection remediation.
· Experience
supporting innovative biologics across clinical, pre-licensure, launch, and
post-licensure phases in multiple markets.
· Expertise in
data integrity, computerized-system compliance, and risk governance for digital
and AI-enabled GxP applications.
· Experience
with combination products, antibody conjugates, advanced manufacturing
technologies, or other emerging modalities.
· Demonstrated
ability to develop global talent, lead through influence, and embed sustainable
quality culture change.
Leadership Profile
·
Enterprise mindset: Connects regulatory
expectations, patient protection, operational performance, and long-term
business strategy.
· Judgment and
courage:
Makes timely, principled decisions and escalates material risk with clarity and
independence.
· Global
influence:
Builds trust across cultures, functions, sites, and leadership levels
· Execution
excellence: Converts strategy into scalable and sustainable standards,
ownership, milestones, and outcomes.
· Continuous
improvement: Uses data, trends, lessons learned, and external insight
to strengthen compliance maturity.